Open | $62.810 |
Close | $63.350 |
Volume / Avg. | 4.678M / 6.023M |
Day Range | 60.300 - 65.700 |
52 Wk Range | 8.280 - 99.410 |
Market Cap | $6.797B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | % |
Days to Cover | 4.9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Viking Therapeutics (NASDAQ: VKTX) through any online brokerage.
Other companies in Viking Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS) and Karuna Therapeutics (NASDAQ:KRTX).
The latest price target for Viking Therapeutics (NASDAQ: VKTX) was reported by Stifel on Friday, March 15, 2024. The analyst firm set a price target for 80.00 expecting VKTX to rise to within 12 months (a possible 27.02% upside). 34 analyst firms have reported ratings in the last year.
The stock price for Viking Therapeutics (NASDAQ: VKTX) is $62.98 last updated March 18, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Viking Therapeutics.
Viking Therapeutics’s Q1 earnings are confirmed for Wednesday, April 24, 2024.
There is no upcoming split for Viking Therapeutics.
Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.